Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin L Jones

Showing results (301-310 of 393) with videos related to

Pageof 40
Sort By:
JAMA Oncology|March 31, 2022
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical TrialRobin L Jones, Vinod Ravi, Andrew S Brohl, et al.
JAMA Oncology|September 10, 2020
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical TrialSeth M Pollack, Mary W Redman, Kelsey K Baker, et al.
Molecular Cancer Therapeutics|November 12, 2020
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue SarcomaJavier Martín-Broto, Antonio López Pousa, Andrew S Brohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2021
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous <i>KIT/PDGFRA</i> Mutations in the Phase III INVICTUS StudySebastian Bauer, Michael C Heinrich, Suzanne George, et al.
Cancers|August 23, 2020
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 PandemicEugenie Younger, Alannah Smrke, Emma Lidington, et al.
Cancer Medicine|July 23, 2024
Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wallMadhumeeta Chadha, Sara Iadecola, Andrew Jenks, et al.
Cancers|July 2, 2021
The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort StudyAnne-Rose W Schut, Milea J M Timbergen, Emma Lidington, et al.
Clinical Sarcoma Research|September 22, 2016
Current status and unanswered questions on the use of Denosumab in giant cell tumor of boneCzar Louie Gaston, Robert J Grimer, Michael Parry, et al.
The Oncologist|December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal TumorsCissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
EJNMMI Research|January 14, 2021
The role of [<sup>68</sup> Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)Luigi Aloj, Olivier Giger, Iosif A Mendichovszky, et al.
Pageof 40

Showing results (301-310 of 393) with videos related to

Sort By:
Pageof 40
JAMA Oncology|March 31, 2022
Efficacy and Safety of TRC105 Plus Pazopanib vs Pazopanib Alone for Treatment of Patients With Advanced Angiosarcoma: A Randomized Clinical TrialRobin L Jones, Vinod Ravi, Andrew S Brohl, et al.
JAMA Oncology|September 10, 2020
Assessment of Doxorubicin and Pembrolizumab in Patients With Advanced Anthracycline-Naive Sarcoma: A Phase 1/2 Nonrandomized Clinical TrialSeth M Pollack, Mary W Redman, Kelsey K Baker, et al.
Molecular Cancer Therapeutics|November 12, 2020
Circulating Tumor Cells and Biomarker Modulation with Olaratumab Monotherapy Followed by Olaratumab plus Doxorubicin: Phase Ib Study in Patients with Soft-Tissue SarcomaJavier Martín-Broto, Antonio López Pousa, Andrew S Brohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2021
Clinical Activity of Ripretinib in Patients with Advanced Gastrointestinal Stromal Tumor Harboring Heterogeneous <i>KIT/PDGFRA</i> Mutations in the Phase III INVICTUS StudySebastian Bauer, Michael C Heinrich, Suzanne George, et al.
Cancers|August 23, 2020
Health-Related Quality of Life and Experiences of Sarcoma Patients during the COVID-19 PandemicEugenie Younger, Alannah Smrke, Emma Lidington, et al.
Cancer Medicine|July 23, 2024
Proteomic profiling improves prognostic risk stratification of the Sarculator nomogram in soft tissue sarcomas of the extremities and trunk wallMadhumeeta Chadha, Sara Iadecola, Andrew Jenks, et al.
Cancers|July 2, 2021
The Evaluation of Health-Related Quality of Life Issues Experienced by Patients with Desmoid-Type Fibromatosis (The QUALIFIED Study)-A Protocol for an International Cohort StudyAnne-Rose W Schut, Milea J M Timbergen, Emma Lidington, et al.
Clinical Sarcoma Research|September 22, 2016
Current status and unanswered questions on the use of Denosumab in giant cell tumor of boneCzar Louie Gaston, Robert J Grimer, Michael Parry, et al.
The Oncologist|December 10, 2020
Optimal Avapritinib Treatment Strategies for Patients with Metastatic or Unresectable Gastrointestinal Stromal TumorsCissimol P Joseph, Sarah N Abaricia, Michelle A Angelis, et al.
EJNMMI Research|January 14, 2021
The role of [<sup>68</sup> Ga]Ga-DOTATATE PET/CT in wild-type KIT/PDGFRA gastrointestinal stromal tumours (GIST)Luigi Aloj, Olivier Giger, Iosif A Mendichovszky, et al.
Pageof 40